Search Within

Andrew D Zelenetz

  1. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (71)
  2. Journal Article (34)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (106)
  2. Department of Medicine (106)
  3. Executive Committee, Center for Hematologic Malignancies (106)
  4. Hematologic Malignancies, Division of (106)
  5. Lymphoma (106)
  6. Survivorship Research (72)

More Groups

People
  1. Anas Younes (88)
  2. Maria Palomba (72)
  3. Matthew Matasar (69)
  4. Paul Hamlin (64)
  5. Anita Kumar (63)
  6. Ariela Noy (63)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (9)
  5. 2020 (11)
  6. 2019 (16)

More Years

Publications
  1. Blood (48)
  2. Hematological Oncology (11)
  3. Journal of Clinical Oncology (6)
  4. Blood Cancer Journal (5)
  5. Leukemia and Lymphoma (5)
  6. Haematologica (4)

More Publications

Publishers
  1. American Society of Hematology (51)
  2. Wiley Blackwell (11)
  3. Nature Publishing Group (9)
  4. American Society of Clinical Oncology (6)
  5. Taylor & Francis Group (5)
  6. American Association for Cancer Research (4)

More Publishers

Results (106)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin
    Meeting Abstract

    Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of Chronic Lymphocytic Leukemia B cells
    Meeting Abstract

    Palomba, M. L.; Piersanti, K.; Ziegler, C. G. K.; Cotari, J. ; Balderas, R.; Malek, S. N.; Seymour, E.; Zelenetz, A. D.; van den Brink, M. R. M.; Altan-Bonnet, G.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Chronic lymphocytic leukemia (CLL) signaling profiling identifies CLL-specific signaling impairment that discriminates CLL B-cells from normal circulating B cells
    Meeting Abstract

    Palomba, M. L.; Piersanti, K.; Zelenetz, A. D.; van den Brink, M. R. M.; Altan-Bonnet, G.
    Blood (2010)

    Fulltext@MSK | Save
  • Signal transduction in chronic lymphocytic leukemia (CLL) cells by multiparameter flow-cytometry
    Meeting Abstract

    Palomba, M. L.; Patel, J. P.; Rao, U.; Rastalsky, N.; Lu, S. X.; Houghton, A. N.; Zelenetz, A. D.; Van Den Brink, M. R.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Analysis of 121 allograft recipients for the treatment of lymphoma: Progressive disease by functional and/or CT imaging is a critical determinant of survival
    Meeting Abstract

    Sauter, C. S.; Moskowitz, C. H.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; Young, J. W.; Van Den Brink, M.; Zelenetz, A. D.; Castro-Malaspina, H. R.
    Blood (2007)

    Fulltext@MSK | Save